Navigation Links
Cardium Provides Update On Exchange Listing
Date:12/20/2013

SAN DIEGO, Dec. 20, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing.  As previously reported, a communication from the staff of the company's current listing exchange, NYSE MKT, indicated that the company was considered to be noncompliant with certain listing requirements based on its quarterly report for the period ended September 30, 2012, and provided that the company should submit a plan to staff of the exchange that would reestablish compliance with the NYSE MKT listing requirement by March 31, 2013, which has since been extended on a quarterly basis based on the company's ongoing progress with its compliance plan. In addition, based on the company's quarterly report on Form 10-Q filed on November 19, 2013, noncompliance was noted with respect to Section 1003(a)(iii) of the company guide which requires the maintenance of stockholders' equity in excess of $6.0 million. Accordingly, the exchange has invited the company to submit an additional plan of compliance by January 6, 2014, pursuant to which the company would expect to regain compliance by May 30, 2014.

The notification received from the listing exchange had no current effect on the listing of the company's shares on the exchange.  Rather the Company has been afforded the opportunity to regain compliance with the requirements of the exchange's company guide by the end of the applicable periods on December 31, 2013 (with respect to Section 1003(a)(iv)) and, if a revised plan is accepted, by May 30, 2014 (with respect to Section 1003(a)(iii)). As is normal course, however, the Company's exchange compliance will continue to be evaluated on an ongoing basis.  Additional information and provisions regarding the NYSE MKT requirements are found in Part 10 of its company guide.  The Company will be subject to periodic review by the exchange staff during the period covered by the plan. 
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cardium to Present at Upcoming Investor Conferences
2. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
3. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
4. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
5. Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan
6. Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013
7. Cardiums To Go Brands Acquired By Cell-nique And Healthy Brands Collective
8. New Resource Provides Herb Industry With Sources of Quality Specifications
9. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
10. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Cynvenio, a cancer ... through the genomic analysis of tumor cells in the ... a web-based cancer decision support application powered by CollabRx, ... Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast ...
(Date:1/15/2014)... , Jan. 15, 2014 ­ RedBrick Health ... behavior change technology, today announces that EmblemHealth , ... and wellness company, is now providing the RedBrick Compass ... coaching program, to all of its members. EmblemHealth is ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
(Date:1/15/2014)... Two champions of science, technology, engineering, and ... annual competition for middle and high school students designed ... study. The competition presents students with real-world problems experienced ... Mathematics, and Sciences is a program administered by ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: ... been named the 2009 Life Sciences Company of the ... presented by LifeSciences British Columbia to recognize a local ... of British Columbia,s life sciences industry. This award recognizes ...
... Calif., April 9 Cell Biosciences, a provider of ... the closing of a $10 million Series C financing ... Existing investors Domain Associates, Latterell Venture Partners, Novo A/S, ... Group also participated in the financing."We are very happy ...
... April 9 Cepheid (Nasdaq: CPHD ) today ... first quarter ended March 31, 2009, on Thursday, April 23, ... a management presentation at 2 p.m. Pacific Time on Thursday, ... the live webcast, please visit Cepheid,s website at ...
Cached Biology Technology:OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 3Cell Biosciences Closes $10 Million Series C Financing 2Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast 2
(Date:4/17/2014)... IPCC meeting painted a stark warning on the possible ... a greenhouse effect 32 times that of carbon dioxide. ... humic substances act as fully regenerable electron acceptors which ... in wetlands instead of being released to the atmosphere. ... disrupted it may enter into a vicious cycle to ...
(Date:4/17/2014)... process whereby the genetic information of DNA is ... which have numerous different functions in living organisms. ... during gene expression, by relating the genetic information ... manufacturing proteins. , By examining the different ... an organism at a given time, researchers can ...
(Date:4/17/2014)... have uncovered a new way the immune system may ... efforts to use immune cells to treat illness. , ... the immunological equivalent of "neighborhood police" specialized squads ... organ, instead of an entire city, the body. , ... Louis have shown that the liver, skin and uterus ...
Breaking Biology News(10 mins):Methane climate change risk suggested by proof of redox cycling of humic substances 2Rapid and accurate mRNA detection in plant tissues 2Some immune cells defend only 1 organ 2
... dominant male and female to reduce their personal contribution to ... in Functional Ecology . , By removing the large ... cycle in this species a team from the University ... investment strategies of the dominant pair and the survival of ...
... Albert Einstein College of Medicine of Yeshiva ... as its twelfth Institutional Founding Member (IFM). A collaboration ... organizations, NYGC aims to transform medical research and clinical ... facilities in North America. "Einstein is pleased to ...
... directly lead to new ways of designing trials that would ... next few years and could change outcome for patients." ... 2013 will build on topics discussed in previous years and ... video here[ http://www.youtube.com/watch?v=X_anpC5WZPg ]: Breast cancer heterogeneity ...
Cached Biology News:Einstein joins the New York Genome Center as 12th institutional founding member 2IMPAKT -- Translational research breast cancer conference 2IMPAKT -- Translational research breast cancer conference 3
...
... the Adept CE 4100 high pressure dual piston ... wavelength detector for added flexibility. The ... and interface unit, CE 4901., The CE 4901 ... be used with Windows 98 and 2000, offers ...
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
... G|2 Doublestain System is a high-sensitivity ... kit. The kit is intended for ... detection of two different antigens within ... with suitably diluted rabbit and mouse ...
Biology Products: